The Role of an Amphiphilic Capping Group in Covalent and Non-Covalent Dipeptide Inhibitors of HCV NS3 Serine Protease

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 113-117

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR Analysis and Molecular Docking Simulation of Suggested Peptidomimetic NS3 Protease Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 10, Iss. 1, 2014-03 ,pp. : 28-40

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Docking Studies on a Series of Benzothiadiazine Derivatives as Genotype 1 HCV Polymerase Inhibitors

By  

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1099-1107

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of NS3 protease inhibitors in HCV infection

By Goudreau Nathalie   Llinàs-Brunet Montse  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1129-1144

Informa Healthcare

Access to resources Recommend Favorite

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite